Peripheral Nerve Stimulation for Occipital Neuralgia: Surgical Leads ⭈ James Sable Leonardo Kapural

Peripheral Nerve Stimulation for Occipital Neuralgia: Surgical Leads ⭈ James Sable Leonardo Kapural

Slavin KV (ed): Peripheral Nerve Stimulation.
Prog Neurol Surg. Basel, Karger, 2011, vol 24, pp 86–95
Peripheral Nerve Stimulation for Occipital
Neuralgia: Surgical Leads
Leonardo Kapural ⭈ James Sable
Pain Management Department, Cleveland Clinic, Cleveland, Ohio, USA
Abstract
Peripheral nerve stimulation (PNS) has been used for the treatment of various neuropathic pain
disorders, including occipital neuralgia, for the patients who failed less-invasive therapeutic
approaches. Several different mechanisms of pain relief were proposed when PNS is used to treat
occipital neuralgia and clinical studies using various types of electrical leads suggested largely
positive clinical responses in patients with mostly refractory, severe neuropathic pain. With
advancements in cylindrical lead design for PNS and placement/implantation techniques, there
are very few clear indications where ‘paddle’ (surgical) leads could be advantageous. Those include
patients who experienced repeated migration of cylindrical lead as paddle lead may provide
greater stability, who are experiencing unpleasant recruitment of surrounding muscle and/or
motor nerve stimulation and for cases where skin erosions were caused by a cylindrical lead.
However, disregarding the type of lead used, multiple clinical advantages of this minimally invasive, easily reversible approach include relatively low morbidity and a high treatment efficacy.
Copyright © 2011 S. Karger AG, Basel
Peripheral nerve stimulation (PNS) is a term generally used to describe techniques
for the treatment of neuropathic pain utilizing various types of leads containing electrodes that are positioned around the affected peripheral nerves. Such approaches
can be used in the treatment of neuropathic pain of different origins, located in areas
that are difficult to reach using spinal cord stimulation (SCS), including the skull, face
and occiput. As a rule, the painful area should be limited, pain severe, and the patient
should fail other less-invasive therapies and interventions. As new approaches have
been developed to more selectively target areas of pain and provide more efficient
paresthesia coverage, the list of indications and new modalities of neurostimulation
emerged [1].
Fig. 1. Currently, most common approach
when PNfS trialed for occipital neuralgia is a
submastoid approach. Lead (usually cylindrical
octopolar lead) is positioned across the occiput
via 14 G epidural Tuohy needle. Needle containing flexible, plastic stylette is preferable, as it
allows free modeling of its shape, approximating better horizontal curve of the occiput of the
individual’s head at the C1-C2 level.
Classification and Terminology
Classically, ‘PNS is a procedure that targets a single nerve and attempts to produce a
paresthesia that spreads along the territory innervated by the stimulated nerve’ [2].
Recently, another clinical application of minimally invasive PNS was described [3]
where significant open dissection near the peripheral nerve is avoided and near nerve
electrode placement achieved. Subsequently in use now are two types of PNS: one
minimally invasive approach using cylindrical leads and imaging guidance (ultrasound or CT), and classical nerve dissection where the nerve is exposed and lead
placed directly to the nerve stimulated.
Peripheral nerve field stimulation (PNfS) is a somewhat different technique where
the goal is to ‘produce a field of paresthesia within the peripheral distribution of pain
by creating an electrical field around the activated bipoles’ [2]. In PNfS, the leads
are placed subcutaneously in the area of pain to stimulate the region of the affected
nerves or the dermatomal distribution of these nerves (fig. 1, 2). Recently, initial successes of PNfS using cylindrical and paddle leads have been reported in a growing list
of clinical settings, primarily in the head and cervical regions [4–8].
Mechanism of Action and History of PNS
Like in SCS, the mechanism of pain suppression provided by PNS is thought to
be based on the gate control theory of pain [1]. Chronic and spontaneous afferent
PNS for Occipital Neuralgia
87
Fig. 2. Schematic of the
paddle leads final position
when used for the bilateral
occipital neuralgia. (Used with
permission from [24]).
activity can be inhibited by electrical stimulation of the proximal portion of the
affected nerve, suggesting another mechanism through which peripheral nerve stimulation may decrease at least neuropathic pain [9]. Other proposed mechanisms of
pain relief include subcutaneous electrical conduction, dermatomal and myotomal
electrical stimulation, partial sympathetic blockade and local blood flow alteration
[9–11]. Occipital nerve stimulation (ONS) is directed to distal branches of the C2 and
C3, which form greater and lesser occipital nerves. As the occipital nerve is a functional part of trigeminocervical complex (TCC), its stimulation may inhibit central
nociceptive transmission and provide pain relief from various types of headaches [10,
11].
Over the years, PNS has had lesser therapeutic importance than SCS, for several
reasons: lack of scientific investigation, lack of complex trialing, and implantation via
surgical exploration of the peripheral nerve with placement of a flat plate multicontact electrode (a paddle electrode) immediately next to it. Such traditional methods
of surgically placing the lead continued to be time consuming and reports of nerve
injury from electrode insertion or stimulation-related fibrosis made PNS less attractive as a pain-relieving modality [1]. The current FDA-approved electrode for PNS is
a homologue of the electrode used for SCS to which a Gortex mesh has been added
to allow its fixation to adjacent tissues. Unfortunately, such design does not allow
88
Kapural · Sable
multiple contacts to provide uniform stimulation to a nerve trunk, the diameter of
which may vary in size [1]. The PNfS technique of lead insertion in the vicinity of the
occipital nerves to treat occipital neuralgia renewed interest in the effectiveness of
PNS in general [4–8].
Occipital Neuralgia
Occipital neuralgia is described as ‘pain, usually deep and aching, in the distribution
of the second cervical dorsal root’ according to the International Association for the
Study of Pain (IASP) [12]. Symptomatology commonly manifests itself as pain that is
lancinating in character, with paroxysmal exacerbations, and is distributed from the
inter-nuchal line (between occipital protuberance and mastoid process) with radiations around the hemicranium up to the supraorbital ridge.
The anterior rami of the upper four cervical nerves unite to form the cervical
plexus, which supplies the skin and muscles of the neck. The posterior primary ramus
of C1 is a motor nerve and supplies multiple muscles. The posterior primary ramus of
C2 emerges between the posterior arch of the atlas and the lamina of the axis, curves
around the inferior border of the inferior oblique muscle, to which it sends a branch
and then divides into a large medial and a small lateral branch. The medial branch is
the greater occipital nerve. This pierces semispinalis capitis and then trapezius. This
may have profound implications for ONS as closeness of the muscles at the height (and
depth) where the leads are positioned may produce unwanted muscle stimulation. The
lesser occipital nerve (C2) hooks around the spinal accessory nerve (XI) then ascends
along the posterior border of the sternocleidomastoid. It pierces the deep fascia in
the upper part of the medial aspect of the posterior triangle. It then splits up into the
auricular, mastoid, and occipital branches. The occipital branch is sensory to the skin
in the occipital area immediately above and behind the mastoid [13, 14].
The possible sources of cervical spinal pain that might be referred to the head
are dictated by the distribution of the upper three cervical spinal nerves. Through
their various branches these nerves innervate the joints and ligaments of the median
atlanto-axial joint, the atlanto-occipital joint, and lateral atlanto-axial joints, the C2C3 zygapophyseal joint, the suboccipital and upper posterior neck muscles, the upper
prevertebral muscles, the spinal dura mater of the posterior cranial fossa, the vertebral artery, the C2-C3 intervertebral disc, and the trapezius and sternocleidomastoid
muscles. All of these structures can be sources of pain and should be considered in
the differential diagnosis of cervicogenic headache. In most cases, the cause of the
neuralgia is not found. However, there are examples of occipital neuralgia caused by
lesions to the nerves [13–15].
Patients with occipital neuralgia usually present with an associated cervicogenic
headache. The IASP [12] defines this as ‘attacks of moderate or moderately severe unilateral head pain without change of side, ordinarily involving the whole hemicranium,
PNS for Occipital Neuralgia
89
usually starting in the neck or occipital area, and eventually involving the forehead
and temporal areas, where the maximal pain is frequently located’. ‘The headache
usually appears in episodes of varying duration in the early phase, but with time the
headache frequently becomes more continuous with exacerbations and remissions.
Symptoms and signs such as mechanical precipitation of attacks imply involvement
of the neck’.
The reason for globalized pain in occipital neuralgia is explained by convergence
between cervical and trigeminal afferents in the spinal cord [16]. Afferents of the
trigeminal nerve descend through the spinal tract of the trigeminal nerve. Their collaterals terminate in the pars caudalis of the spinal nucleus of the trigeminal nerve
and in the dorsal horns of their respective segment, and send ascending and descending collaterals to adjacent segments. Therefore, at any given cervical segment, secondorder neurons that project to higher centers can receive a convergent input from
afferents of the trigeminal nerve and the C1, C2, and C3 spinal nerves [13–16].
Indications and Technique for the Implantation of Paddle Leads
The usual indications for PNS using paddle leads are similar to those for SCS procedures. The pain has to be chronic, severe, negatively affecting patient’s functionality,
and refractory to usual medical treatments. With advancements in cylindrical lead
design and placement/implantation techniques, there are very few clear indications
where ‘paddle’ leads could be advantageous when compared to cylindrical. The argument could be made that the placement of paddle leads is associated with less scar
tissue formation around the electrode, better field of stimulation, and less of lead
migration. Therefore, patients considered for ONS using paddle leads are frequently
those who have already had implanted cylindrical leads that migrated and required
revisions, sometimes several (fig. 3). The main advantage of plate electrodes is their
greater inherent stability, as they are believed to have less propensity to migrate [5, 9,
14]. The lead migration rate for cylindrical leads implanted for ONS can vary between
9 and 33% [17, 18]. Such migration rates are believed to persist over long-term use,
and may happen later during its therapeutic use [18]. Although prospective comparison studies related to lead migration are lacking, a large overview of paddle lead use
for various indications in the epidural space in the hands of experienced neurosurgeon suggested a significantly lower rate of migration, only 1.1% [19].
Plate electrodes are also more energy efficient. Multiple arrays or different electrode
configurations can be constructed with plate electrodes. The insulating side of the plate
electrode isolates the contacts from dorsal structures and, using much larger crosssectional area then a cylindrical electrode, brings the entire contact surface ventrally,
closer to the stimulated nerve [20]. Therefore, another indication for the implantation of
paddle leads may include patients who are experiencing unpleasant recruitment of surrounding muscle and/or motor nerve stimulation when cylindrical lead is used [21].
90
Kapural · Sable
a
b
Fig. 3. a, b Same female patient after percutaneous (a) and surgical (b) permanent lead implantation. Here illustrated indication is currently one of the most common for the implantation of
surgical paddle leads. Patient lost adequate stimulation after the cylindrical leads migrated and, in
addition, produced localized discomfort in the left occipital area when stimulation turned on.
Replacement with surgical paddle leads resulted in restored occipital coverage with more even,
stable stimulation.
Finally, another likely indication for the implantation of paddle leads is the presence of repeated skin erosions caused by a cylindrical lead within the delicate area of
the posterior neck, which contains minimal subcutaneous fat. During cylindrical lead
implantation a Tuohy needle is used to position the lead in the occipital region. As
the curve of the occipital region does not perfectly match the curve of a bent Tuohy
needle, the needle itself and eventually the lead can terminate at a point much more
superficial to the skin at its distal aspect, increasing the risk for skin erosion [22].
Although deeper needle placement may decrease the risk of erosion, it can in turn
increase the risk of direct muscle stimulation [21].
Lateral and medial approach to both ‘paddle’ and cylindrical leads placement have
been described (table 1). The technique originally described by Weiner et al. [8], later
continued by Slavin et al. [6] and recently detailed by Trentman et al. [23] involved lateral incision close to the mastoid process. Later, midline placement was described and
it has been the approach that we use in our institution. Arguments can be made that
the midline incision is better due to presence of more subcutaneous fat in the midline
of the neck, leaving enough space for anchoring and loop placement (fig. 2) without
adding more discomfort to the patient. In addition, if bilateral leads are required, only
one small midline incision over the upper neck is used to achieve stimulation of both
greater and other occipital nerves. Still, it seems that the frequency of lead migration
was higher when midline approach was used with cylindrical leads [18]. It is not clear
if the same applies when paddle leads are used via the midline approach [24].
PNS for Occipital Neuralgia
91
Table 1. Outcomes of the studies where ONS was used for the treatment of various headaches, mainly occipital neuralgia
Study
Technique
Oh et al.,
2004 [5]
below
mastoid
Kapural et al.,
2005 [25]
Number of
patients
Type of lead
Outcome
20
paddle
14 patients >90% pain reduction at 6
months’ follow-up, 95% improved QoL
midline
6
paddle
VAS decreased at 6 months from 8.66 to
2.5, PDI improvement 49.8 to 14
Johnstone and
Sundaraj, 2006 [26]
midline
8
paddle
5/7 with improvement in VAS, 7/8
reduction in opioid use
Magis et al.,
2007 [27]
below
mastoid
8
paddle
5/8 >90% reduction in pain, 2/8 with 40%
improvement in pain
Jones,
2003 [28]
midline
3
paddle
all 3 ‘excellent’ outcome
Weiner,
2006 [29]
various
150
paddle and
cylindrical
70–75% >50% improvement (VAS and
medication usage)
Weiner et al.,
1999 [4]
below
mastoid
13
cylindrical
2/3 of patients with >75% pain relief and
1/3 with >50% relief
Hammer and Doleys,
2001 [30]
midline
1
cylindrical
90% improvement in pain 9 months’
follow-up
Nörenberg and
Winkelmüller, 2001 [31]
below
mastoid
3
cylindrical
all three >50% improvement in pain
Popeney and Aló,
2003 [32]
below
mastoid
25
cylindrical
100% satisfied at 18 months, 88.7%
improvement in MIDAS scores
Rodrigo-Royo et al.,
2005 [33]
below
mastoid
4
cylindrical
VAS scores to 0 in all patients, global
symptom improvement >50% ×4
Slavin et al.,
2006 [7]
below
mastoid
14
cylindrical
70% adequate pain control, continued
employing, decrease in opioid (22 months)
Slavin et al.,
2006 [6]
below
mastoid
30
cylindrical
22/30 >50% pain reduction trial, 16/22
implants >50% pain reduction
Schwedt et al.,
2007 [18]
midline
15
cylindrical
improvement in HIT-6 by 11 and BDI by 20
Burns et al.,
2007 [34]
midline
8
cylindrical
20 months’ follow-up, 5/8 with >40%
improvement in pain
Melvin et al.,
2007 [17]
midline
11
cylindrical
VAS, PPI, medication use and number of
attacks reduced in >64%
Trentman et al.,
2008 [35]
below
mastoid
10
cylindrical
all improved, 20 months’ follow-up
Described are outcomes of the patients who had paddle lead implants (first 5 rows) and cylindrical lead implants. Please note
that descriptive outcomes did not allow comparison between the groups. QoL = Quality of life; PDI = Pain Disability Index.
92
Kapural · Sable
Similar to the placement of cylindrical lead, patients are positioned prone with
support under the chest and forehead, and prepared and draped over the occipital
area, neck, and parts of the upper and lower back and left or right upper buttock.
Initial incision is made in the nuchal region about 3 cm in length, positioned craniocaudal for either bilateral or unilateral lead implants. Subcutaneous blunt dissection is
then completed from the midline bilaterally at the level of C1-C2 and a pocket created
using a ‘hockey stick-like’ plastic introducer in the shape of the surgical lead. Leads
are then positioned and the patient awakened for the intraoperative trial of stimulation. After complete coverage in the painful occipital area has been confirmed by
the patient, leads are anchored in position subcutaneously. We usually place a ‘strain
relief ’ loop at the implant site (fig. 2). This is loosely sutured at three points to the
subcutaneous tissue, the intention being to reduce tension on the lead during flexion. Later, the pulse generator is connected to the two leads by extension cables that
were drawn through a subcutaneous tunnel and placed in a pocket in the buttock.
We speculated earlier that such a midline approach using ‘paddle’ leads and extensive
anchoring may provide less strain on the lead extension as it occurs only with flexion
and is minimal with lateral flexion and rotation of the neck [25].
Clinical Outcomes and Peer-Reviewed Evidence
It needs to be emphasized that the patient group treated using this invasive approach
are those patients who were unresponsive to all prior conservative and interventional
procedures and uniformly had had uncontrolled occipital headaches despite increasing dosages of membrane stabilizers, antidepressants, and opioids. Clinical outcomes
of patient groups receiving paddle leads were illustrated in table 1 and descriptively
compared to those patient groups receiving cylindrical leads. Either group of the
patients achieved very good outcomes and it is impossible to speculate if the use of
either type of electrodes provides better long-term improvements in pain, function
or frequency of various headaches, including occipital neuralgia. As the implantation
of surgical (paddle) leads causes more tissue injury, it should be reserved for patients
with the indications listed above.
Complications
The complication rate for PNS when paddle (surgical) leads are used is generally low,
but both minor and major complications have been reported, including local infections, hardware erosions, component disconnections, electrode fractures and displacements, and even sepsis. Perineural fibrosis, described in the past with the use of
plate or wraparound electrodes with so-called ‘On-Point’ PNS electrodes (Medtronic,
Minneapolis, Minn., USA) is much less likely with the current ONS application of the
PNS for Occipital Neuralgia
93
paddle leads which essentially serve as PNfS. Still, the most frequent complication of
any subcutaneous techniques for ONS is lead migration necessitating electrodes revision [17–19]. Paddle lead implantation may improve lead stability [19], as suggested
in multiple reviews and study discussion, although there is no clear evidence in the
form of a prospective study to confirm such a claim (please see section on indications
for paddle lead implantation).
When clinically compared to spinal cord stimulation, wound dehiscence and infection are associated with lower overall morbidity; however, these complications usually require total system explantation. Another complication that can lead to failure
of the system is unpleasant muscle recruitment causing spasm in the neck or occipital
region. Recently, a report of a case series suggested that such problem may be less
frequent when paddle leads are used [21].
Conclusions
PNS and especially ONS as a treatment modality is seeing a resurgence, with new
evidence and widespread use demonstrating effectiveness in attenuating pain and
improving function in patients not only with neuralgia that is not controlled with
medications, but also in the treatment of migraine and cluster headaches. More
research is needed to clearly assess the long-term effectiveness of this treatment. Such
use of PNfS does provide multiple clinical advantages, namely, it is easily reversible,
minimally invasive, and has relatively low morbidity.
References
1 Stanton-Hicks M: Peripheral nerve stimulation for
pain: peripheral neuralgia and complex regional
pain syndrome; in Krames ES, Peckham H, Rezai
AR (eds): Neuromodulation. Philadelphia, Elsevier,
2009, pp 397–407.
2 Abejon D, Krames ES: Peripheral nerve stimulation
or is it peripheral subcutaneous field stimulation;
what is in a moniker? Neuromodulation 2009;12:1–4.
3 Huntoon MA, Burgher AH: Ultrasound guided
permanent implantation of peripheral nerve stimulation (PNS) system for neuropathic pain of the
extremities: original cases and outcomes. Pain Med
2009;10:1369–1377.
4 Weiner RL, Reed KL: Peripheral neurostimulation
for control of intractable occipital neuralgia.
Neuromodulation 1999;2:217–221.
5 Oh MY, Ortega J, Bellotte JB, Whiting DM, Aló K:
Peripheral nerve stimulation for the treatment of
occipital neuralgia and transformed migraine using a
C1–2–3 subcutaneous paddle style electrode: a technical report. Neuromodulation 2004;7:103–112.
94
6 Slavin KV, Colpan ME, Munawar N, Wess C,
Nersesyan H: Trigeminal and occipital peripheral
nerve stimulation for craniofacial pain: a singleinstitution experience and review of the literature.
Neurosurg Focus 2006;21:E5.
7 Slavin KV, Nersesyan H, Wess C: Peripheral neurostimulation for treatment of intractable occipital
neuralgia. Neurosurgery 2006;58:112–119.
8 Weiner RL, Aló KM: Occipital neurostimulation
(ONS) for treatment of intractable headache syndromes; in Krames ES, Peckham H, Rezai AR (eds):
Neuromodulation. Philadelphia, Elsevier, 2009, pp
409–416.
9 Burchiel KJ: Effects of electrical and mechanical
stimulation on two foci of spontaneous activity
which develop in primary afferent neurons after
peripheral axotomy. Pain 1984;18:249–265.
10 Goadsby PJ, Knight YE, Hoskin KL: Stimulation of
the greater occipital nerve increases metabolic
activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain 1997;73:23–28.
Kapural · Sable
11 Bartsch T, Goadsby PJ: Stimulation of the greater
occipital nerve induces increased central excitability
of dural afferent input. Brain 2002;125:1496–1509.
12 International Association for the Study of Pain: In
Merskey H, Bogduk N (eds): Classification of Chronic
Pain, ed 2. Seattle, IASP Press, 1994, pp 1–224.
13 Loeser JD: Cranial neuralgias; in Loeser JD (ed):
Bonica’s Management of Pain, ed 3. Philadelphia,
Lippincott, Williams & Wilkins, 2001, pp 855–866.
14 Jasper J, Hayek SM: Implanted occipital nerve stimulators. Pain Physician 2008;11:187–200.
15 Bogduk N: Cervicogenic headache: anatomic basis
and pathophysiologic mechanisms. Curr Pain
Headache Rep 2001;5:382–386.
16 Piovesan EJ, Kowacs PA, Tatsui CE, Lange MC,
Ribas LC, Werneck LC: Referred pain after painful
stimulation of the greater occipital nerve in humans:
evidence of convergence of cervical afferents on
trigeminal nuclei. Cephalalgia 2001;21:107–109.
17 Melvin EA Jr, Jordan FR, Weiner RL, Primm D:
Using peripheral stimulation to reduce the pain of
C2-mediated occipital headaches: a preliminary
report. Pain Physician 2007;10:453–460.
18 Schwedt TJ, Dodick DW, Hentz J, Trentman TL,
Zimmerman RS: Occipital nerve stimulation for
chronic headache: long-term safety and efficacy.
Cephalalgia 2007;27:153–157.
19 Barolat G: Experience with 509 plate electrodes
implanted epidurally from C1 to L1. Stereotact
Funct Neurosurg 1993;61:60–79.
20 North RB, Lanning A, Hessels R, Cutchis PN: Spinal
cord stimulation with percutaneous and plate electrodes: side effects and quantitative comparisons.
Neurosurg Focus 1997;15:e3.
21 Hayek SM, Jasper JF, Deer T, Narouze SN: Occipital
neurostimulation–induced muscle spasms: implications for lead placement. Pain Physician 2009;12:
867–876.
22 Trentman TL, Dodick DW, Zimmerman RS, Birch
BD: Percutaneous occipital stimulator lead tip
erosion: report of 2 cases. Pain Physician 2008;11:
253–256.
23 Trentman TL, Slavin KV, Freeman JA, Zimmerman
RS: Occipital nerve stimulator placement via a retromastoid to infraclavicular approach: a technical
report. Stereotact Funct Neurosurg 2010;88:121–125.
24 Trentman TL, Zimmerman RS: Occipital nerve
stimulation: technical and surgical aspects of
implantation. Headache 2008;48:319–327.
25 Kapural L, Mekhail N, Hayek S, et al: Occipital
nerve electrical stimulation via the midline approach
and subcutaneous surgical leads for treatment of
severe occipital neuralgia: a pilot study. Anesth
Analg 2005;101:171–174.
26 Johnstone CSH, Sundaraj R: Occipital nerve stimulation for the treatment of occipital neuralgia – eight
case studies. Neuromodulation 2006;9:41–47.
27 Magis D, Allena M, Bolla M, et al: Occipital nerve
stimulation for drug-resistant chronic cluster
headache: a prospective pilot study. Lancet 2007;6:
314–321.
28 Jones RL: Occipital nerve stimulation using a
Medtronic Resume II electrode array. Pain Physician
2003;6:507–508.
29 Weiner RL: Occipital neurostimulation (ONS) for
treatment of intractable headache disorders. Pain
Med 2006;7:S137–S139.
30 Hammer M, Doleys DM: Perineuromal stimulation
in the treatment of occipital neuralgia: a case study.
Neuromodulation 2001;4:47–51.
31 Nörenberg E, Winkelmüller W: The epifascial electric stimulation of the occipital nerve in cases of
therapy-resistant neuralgia of the occipital nerve.
Schmerz 2001;15:197–199.
32 Popeney CA, Aló KM: Peripheral neurostimulation
for the treatment of chronic, disabling transformed
migraine. Headache 2003;43:369–375.
33 Rodrigo-Royo MD, Azcona JM, Quero J, Lorente
MC, Acín P, Azcona J: Peripheral neurostimulation
in the management of cervicogenic headaches: four
case reports. Neuromodulation 2005;4:241–248.
34 Burns B, Watkins L, Goadsby PJ: Treatment of medically intractable cluster headache by occipital nerve
stimulation: long-term follow-up of eight patients.
Lancet 2007;369:1099–1106.
35 Trentman TL, Zimmerman RS, Seth N, Hentz JG,
Dodick DW: Stimulation ranges, usage ranges, and
paresthesia mapping during occipital nerve stimulation. Neuromodulation 2008;11:56–61.
Leonardo Kapural, MD, PhD
Carolinas Pain Institute
Center for Clinical Research
Winston-Salem, NC 27103 (USA)
Fax +1 216 444 9890, E-Mail [email protected]
PNS for Occipital Neuralgia
95